Aethlon Medical, Inc. (NASDAQ:AEMD) Short Interest Update

Aethlon Medical, Inc. (NASDAQ:AEMD) was the target of a significant increase in short interest during the month of April. As of April 15th, there was short interest totalling 29,800 shares, an increase of 57.7% from the March 31st total of 18,900 shares. Currently, 1.3% of the shares of the stock are sold short. Based on an average daily volume of 8,200 shares, the short-interest ratio is currently 3.6 days.

Wall Street Analysts Forecast Growth

Several analysts recently commented on AEMD shares. StockNews.com started coverage on shares of Aethlon Medical in a research note on Saturday, April 20th. They set a “sell” rating for the company. HC Wainwright cut their price target on shares of Aethlon Medical from $23.00 to $10.00 and set a “buy” rating on the stock in a report on Monday, March 4th.

Aethlon Medical Stock Performance

Aethlon Medical stock opened at $1.37 on Friday. The firm has a market cap of $3.59 million, a PE ratio of -0.27 and a beta of 1.88. The firm’s 50 day moving average price is $1.64 and its two-hundred day moving average price is $1.75. Aethlon Medical has a twelve month low of $1.33 and a twelve month high of $5.00.

Aethlon Medical (NASDAQ:AEMD) last released its quarterly earnings data on Wednesday, February 14th. The medical equipment provider reported ($1.37) earnings per share for the quarter, missing the consensus estimate of ($1.23) by ($0.14). Equities analysts anticipate that Aethlon Medical will post -4.98 EPS for the current fiscal year.

Aethlon Medical Company Profile

Aethlon Medical, Inc, a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses and use in organ transplantation.